JEANNETTE SAMPSON: Open Payments
NPI 1275091266 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,152 in 42 payments from 8 companies in 2025. Trend: 2023 $182 · 2024 $248 · 2025 $2,152
Food & beverage: $2,152
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $618 |
| Alkermes, Inc. | 6 | $332 |
| Braeburn Inc. | 9 | $321 |
| Axsome Therapeutics, Inc. | 4 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $256 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 1 | $124 |
| Otsuka America Pharmaceutical, Inc. | 1 | $110 |
Products named: VRAYLAR, BRIXADI, Auvelity, CAPLYTA, VIVITROL, ARISTADA, COBENFY, FANAPT.
Industry payments across NY — which companies pay providers there.
